Atsena Therapeutics

biotechDurhamseries_c

atsenatx.com

Gene therapy for inherited retinal diseases

At a glance

HQ: Durham
Sector: Biotech
Stage: Series C
Total raised: $150M
Last round: Series C

Open roles

View jobs board

Associate Director or Director, Regulatory Strategy (Clinical & Nonclinical)

RemoteRemote

Senior Director, Medical Affairs

RemoteRemote

Senior Manager, Clinical Quality Operations

RemoteRemote

This is the free preview.

The full profile is for members: founders, funding history, investor connections, and recent signals. Accounts are free; I review every request, usually within 48 hours.